Personal information

Activities

Employment (4)

University of Geneva: Geneva, CH

2023-02 to present | Associate Professor (Department of Medicine)
Employment
Source: Self-asserted source
Thomas Agoritsas

University Hospital of Geneva: Geneva, CH

2017-10 to present | Attending Physician (Division of General Internal Medicine, Department of Medicine)
Employment
Source: Self-asserted source
Thomas Agoritsas

Magic Evidence Ecosystem Foundation: Oslo, NO

2017-08 to present | Chair
Employment
Source: Self-asserted source
Thomas Agoritsas

McMaster University: Hamilton, CA

2016-07 to present | Part-time Professor (Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Science)
Employment
Source: Self-asserted source
Thomas Agoritsas

Education and qualifications (5)

McMaster University: Hamilton, CA

2015-11 | PhD (Department of Health Research Methods, Evidence, and Impact (HEI), Faculty of Science)
Qualification
Source: Self-asserted source
Thomas Agoritsas

FMH/ISFM - Swiss Medical Association: Bern, CH

2011-12 | Board certification in General Internal Medicine
Qualification
Source: Self-asserted source
Thomas Agoritsas

University of Geneva: Geneva, CH

2011-02 | MD: Doctoral Thesis in Medicine (Faculty of Medicine)
Qualification
Source: Self-asserted source
Thomas Agoritsas

University of Geneva: Geneva, CH

1999-10 to 2006-01 | Medical Diploma (Faculty of Medicine)
Qualification
Source: Self-asserted source
Thomas Agoritsas

Erasmus MC: Rotterdam, NL

2002-07 | Certificate in Epidemiology & Biostatistics
Qualification
Source: Self-asserted source
Thomas Agoritsas

Professional activities (7)

Fondation Leenaards: Lausanne, Vaud, CH

2025-03 to present | Expert member (Science and Health Commission (Comission Sciences et Santé))
Service
Source: Self-asserted source
Thomas Agoritsas

World Health Organization: Geneva, Geneva, CH

2020-04-01 to present | Expert guideline methodologist
Service
Source: Self-asserted source
Thomas Agoritsas

Swiss national Cancer Screening Committee Guidelines: Bern, CH

2018-01-01 to present | Expert panel member
Service
Source: Self-asserted source
Thomas Agoritsas

BMJ: London, England, GB

2016-03-01 to present | Co-founder and Co-leader of the BMJ Rapid Recommendations
Service
Source: Self-asserted source
Thomas Agoritsas

American College of Physicians: Philadelphia, Pennsylvania, US

2015-01-01 to present | Deputy Editor at the American College of Physicians Journal Club (ACP JC)
Service
Source: Self-asserted source
Thomas Agoritsas

Swiss Society of General Internal Medicine: Bern, CH

2011 to present | Member
Membership
Source: Self-asserted source
Thomas Agoritsas

FMH: Bern, Bern, CH

2008 to present | Member
Membership
Source: Self-asserted source
Thomas Agoritsas

Funding (20)

Barriers and facilitators for developing and implementing evidence­based practice guidelines during a pandemic: An exploratory mixed­methods study.

2025-01 to 2027-01 | Grant
Canadian Institutes of Health Research (ON, ON, CA)
Source: Self-asserted source
Thomas Agoritsas

Prevalence, Survival, and Financial Challenges: A Population-Based Study on Cancer Survivorship in Geneva and Switzerland

2025-01 to 2027-01 | Grant
Geneva League Against Cancer (Geneva, Geneva, CH)
Source: Self-asserted source
Thomas Agoritsas

Enable the patient knowledge accumulated by the Association for Patient Knowledge to play a concrete and transformative role in the health system, towards more integrative health

Mitigating Antimalarial Resistance Consortium in South-East Africa

2023-04-01 to 2027-03-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 101103076
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Fostering transparency in rheumatology randomized clinical trials

2023-01-01 to 2025-12-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 212393
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Etude de l'impact de la communication thérapeutique basée sur l'hypnose (Hypnosis-Based Therapeutic Communication, HBTC) sur l'interaction soignant-e/soigné-e

2023-01 to 2024-01 | Grant
HUG (Geneva, Geneva, CH)
Source: Self-asserted source
Thomas Agoritsas

Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care

2022-09-01 to 2027-08-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 101057123
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE

2022-09-01 to 2027-08-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 101057099
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Long COVID Web: Pan-Canadian Post-COVID Condition Research Network

2022-04-01 to 2027-03-31 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
GRANT_NUMBER: 202211POS
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Global evidence, local adaptation: Enhancing evidence-informed guideline recommendations for newborn and young child health in three countries in sub-Saharan Africa

2022-04-01 to 2025-07-31 | Grant
European & Developing Countries Clinical Trials Partnership (The Hague, NL)
GRANT_NUMBER:

RIA2020S-3303

Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Discontinuing Statins in Multimorbid Older Adults without Cardiovascular Disease - a Randomized Non-Inferiority Clinical Trial (STREAM)

2021-09-01 to 2026-08-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 193052
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Enhancing the Evidence Ecosystem - through digital, trustworthy and personalized decision support at the point of patient care

2021-01-01 to present | Grant
Southern and Eastern Norway Regional Health Authority (Hamar, NO)
GRANT_NUMBER: 2021060
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Efficacy of same day chemoprophylaxis for exposed asymptomatic individuals exposed to SARS-CoV-2 in Switzerland: a pragmatic open-label cluster randomized trial (COPEP-trial)

2020-06-01 to 2022-10-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 196251
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Living network meta-analysis and rapid recommendations for the treatment of COVID-19

2020-04-01 to 2022-03-31 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
GRANT_NUMBER: 202011MM1
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Living network meta-analysis and Rapid Recommendations for the treatment of COVID-19

2020-04-01 to 2021-03-31 | Grant
Canadian Institutes of Health Research (Ottawa, CA)
GRANT_NUMBER: 202005VR4
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

How did patients like me do? A patient-centred tool (DEdiCADE) to support shared decision-making and long-term follow-up in elective total hip arthroplasty

2019-01 to 2021-01 | Grant
HUG (Geneva, Geneva, CH)
Source: Self-asserted source
Thomas Agoritsas

Main dans la main pour l’avenir des adolescents vulnérables: un nouveau partenariat avec les jeunes patients transgenres

2018-01 to 2020-01 | Grant
HUG (Geneva, Geneva, CH)
Source: Self-asserted source
Thomas Agoritsas

Outils pour une gestion autonome du partnariat

2017-01 to 2019-01 | Grant
HUG (Geneva, Geneva, CH)
Source: Self-asserted source
Thomas Agoritsas

MAGIC: Research program to create clinical practice guidelines we can use, share and trust

2013-01-01 to 2019-12-31 | Grant
Southern and Eastern Norway Regional Health Authority (Hamar, NO)
GRANT_NUMBER: 2013070
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard

Access and Use of Current Best Evidence to Support Health Care Decisions in Clinical Practice: a Cluster Randomized Controlled Trial.

2012-06-01 to 2013-05-31 | Grant
Swiss National Science Foundation (Bern, CH)
GRANT_NUMBER: 142251
Source: Self-asserted source
Thomas Agoritsas via DimensionsWizard